Publications

Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice
Bhattacharya A,  Mamcarz M,  Mullins C, Choudhury A,  Boyle RG,  Smith DG,  Walker DW,  Klann E.
Neuropsychopharmacology. 2015 Dec 28. doi: 10.1038/npp.2015.369. [Epub ahead of print]. PMID:26708105 [PubMed - as supplied by publisher].

Genetic and Acute CPEB1 Depletion Ameliorate Fragile X Pathophysiology
Tsuyoshi Udagawa,Natalie G Farny, Mira Jakovcevski,Hanoch Kaphzan, Juan Marcos Alarcon,Shobha Anilkumar, Maria Ivshin, Jessica A Hurt, Kentaro Nagaoka,Vijayalaxmi C Nalavadi, Lori J Lorenz, Gary J Bassell,Schahram Akbarian,Sumantra Chattarji, Eric Klann,  Joel D Richter.
Nat Med. 2013 Nov;19(11):1473-7. doi: 10.1038/nm.3353. Epub 2013 Oct 20.  PMID: 24141422. PMCID: PMC3823751.

Neuron-Specific Regulation of Class I PI3K Catalytic Subunits and Their Dysfunction in Brain Disorders

Christina Gross, Gary J Bassell.

Front Mol Neurosci. 2014 Feb 13;7:12. doi: 10.3389/fnmol.2014.00012. eCollection 2014.  PMID: 24592210 [PubMed] PMCID: PMC3923137.

Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice

Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E.

Neuron. 2012 Oct 18;76(2):325-37. doi: 10.1016/j.neuron.2012.07.022. Epub 2012 Oct 17.PMID: 23083736.   PMCID: PMC3479445.